• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>NeoPharm

NeoPharm

  1. Stock Star Rating Performance Review

    Our top-rated stocks continue to do well, turning in very respectable performance in 2006. I'm happy that our patient strategy of recommending only stocks trading at a price that includes a reasonable margin of safety is paying off nicely for consumers of our research. As we have for the past few ...

  2. Stock Star Rating Performance Update

    We lost some ground during the second quarter of 2006, but the performance of our top-rated stocks continues to be solid. More importantly, we added a large number of new 5-star stocks to our benchmark portfolio during the market's swoon, and any opportunity to buy companies at bargain prices is a ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.